Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Dec 3:1–8. doi: 10.1080/09537104.2020.1852543

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Taylor & Francis Group, LLC

This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.

PMC Copyright notice

Figure 1. — Comparison of platelet biomarkers in ICU vs. non-ICU patients

The graphs represent the marginal effect plots. The squares and the circles represent the marginal effect at the specific time point. The whiskers are the 95%CI. The lines between squares and circles represent the trend over time. The p-value in the upper right portion of each figure represents the overall difference over time between subgroups.Red line and square: ICU patients. Green line and circle: non-ICU patients.ICU: intensive care unit. AA: arachidonic acid. ADP: adenosine diphosphate. TRAP: thrombin receptor agonist peptide. sCD40L: soluble CD40 ligand.